- Corporate Officers - H
- Henneman John B Iii
Insider Trading History of Henneman John B Iii
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henneman John B Iii since 2015.
This trader's CIK number is 1187572.
At the time of last reporting, Henneman John B Iii was the Officer of Anika Therapeutics, Inc.. (stock ticker symbol ANIK).
Also see all insider trading activities at Anika Therapeutics, Inc..
Note that in the past
HENNEMAN JOHN B III also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Lumos Pharma, Inc. ((NLNK)) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | (NLNK) | 0 | $0 | 175 | $6,254 | 0 | $0 |
| 2015 | (NLNK) | 3,000 | $111,899 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Seaspine Holdings Corp (SPNE) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | SPNE | 0 | $0 | 10,000 | $150,000 | 0 | $0 |
| 2018 | SPNE | 0 | $0 | 10,000 | $146,818 | 17,398 | $216,431 |
Yearly summary of insider trading at Anika Therapeutics, Inc. (ANIK) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | ANIK | 5,000 | $73,320 | 0 | $0 | 0 | $0 |
| 2021 | ANIK | 2,000 | $85,720 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at R1 Rcm Inc. /de (RCM) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | RCM | 0 | $0 | 50,000 | $858,649 | 50,000 | $130,500 |
Yearly summary of insider trading at R1 Rcm Inc. (RCM) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | RCM | 0 | $0 | 0 | $0 | 5,151 | $0 |
| 2016 | RCM | 50,000 | $89,600 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Henneman John B Iii
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | APRE | 6,860 | $50,009 | 0 | $0 | 0 | $0 |
| 2019 | APRE | 5,000 | $75,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Henneman John B Iii:
1. Lumos Pharma, Inc. ((NLNK))
2. Seaspine Holdings Corp (SPNE)
3. Anika Therapeutics, Inc. (ANIK)
4. R1 Rcm Inc. /de (RCM)
5. R1 Rcm Inc. (RCM)
6. Aprea Therapeutics, Inc. (APRE)
Table 1. Insider trading of Lumos Pharma, Inc. ((NLNK)) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-01-05 | (NLNK) | Sale | 175 | 35.74 | 6,254 |
| 2015-05-14 | (NLNK) | Buy | 3,000 | 37.30 | 111,899 |
Table 2. Insider trading of Seaspine Holdings Corp (SPNE) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-08-05 | SPNE | Sale | 10,000 | 15.00 | 150,000 |
| 2018-08-29 | SPNE | Sale | 3,407 | 14.65 | 49,912 |
| 2018-08-27 | SPNE | Sale | 4,564 | 14.72 | 67,182 |
| 2018-08-28 | SPNE | Sale | 2,029 | 14.65 | 29,724 |
| 2018-06-13 | SPNE | Option Ex | 17,398 | 12.44 | 216,431 |
Table 3. Insider trading of Anika Therapeutics, Inc. (ANIK) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-05-01 | ANIK | Buy | 5,000 | 14.66 | 73,320 |
| 2021-05-18 | ANIK | Buy | 2,000 | 42.86 | 85,720 |
Table 4. Insider trading of R1 Rcm Inc. /de (RCM) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-08 | RCM | Option Ex | 50,000 | 2.61 | 130,500 |
| 2023-08-08 | RCM | Sale | 50,000 | 17.17 | 858,649 |
Table 5. Insider trading of R1 Rcm Inc. (RCM) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-21 | RCM | Option Ex | 5,151 | .00 | 0 |
| 2016-08-16 | ACHI | Buy | 50,000 | 1.79 | 89,600 |
Table 6. Insider trading of Aprea Therapeutics, Inc. (APRE) by Henneman John B Iii
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-13 | APRE | Buy | 6,860 | 7.29 | 50,009 |
| 2019-10-07 | APRE | Buy | 5,000 | 15.00 | 75,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Henneman John B Iii
(Officer of Anika Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.